Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

NCT01355913 · clinicaltrials.gov ↗

COMPLETED

Status

402

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes (MDS)
Chromosmal Aberrations
Karyotype Evolution
Rare Abnormalities
Cytogenetic Monitoring

Sponsor

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Collaborators

[object Object]